| ABC | Adenosine triphosphate-binding cassette |
| ABCA1 | ATP-binding cassette transporter A1 |
| ACC | American College of Cardiology |
| ACL | Adenosin triphosphate-citrate lyase |
| AHA | American Heart Association |
| ALT | Alanine Aminotransferase |
| ApoB | Apolipoprotein B |
| ASCVD | Atherosclerotic cardiovascular disease |
| AST | Aspartate Aminotransferase |
| AUC | Area under the curve |
| BCRP | Breast cancer-resistant protein |
| BMI | Body mass index |
| BP | Blood pressure |
| CAC | Coronary artery calcium |
| CAD | Coronary artery disease |
| CK | Creatine Kinase |
| CKD | Chronic kidney disease |
| COPD | Chronic Obstructive Pulmonary Disease |
| CPIC | Clinical Pharmacogenetics Implementation Consortium |
| CVD | Cardiovascular disease |
| CYP450 | Cytochrome P450 |
| DAST | Dietary Approaches to Stop Hypertension |
| DPWG | Dutch Pharmacogenetics Working Group |
| DRESS | Drug reaction with eosinophilia and systemic symptoms |
| ESC | European Society of Cardiology |
| FDA | Food and Drug Administration |
| FH | Familial hypercholesterolemia |
| FHS | Framingham Heart Study |
| HDL | High-density lipoprotein |
| HDL-C | High-density lipoprotein cholesterol |
| HeFH | Heterozygous familial hypercholesterolemia |
| HMG-CoA | β-hydroxy β-methylglutaryl-coenzyme A |
| HoFH | Homozygous familial hypercholesterolemia |
| IBD | Inflammatory Bowel Disease |
| IDL | Intermediate-density lipoproteins |
| IMPROVE-IT | Improved Reduction in Outcomes: Vytorin Efficacy International Trial |
| KDIGO | Kidney Disease: Improving Global Outcomes |
| LDL | Low-density lipoprotein |
| LDL-C | Low-density lipoprotein cholesterol |
| LDLR | Low-density lipoprotein receptor |
| LDLRAP | Low-density lipoprotein receptor adaptor protein |
| LFTs | Liver function tests |
| LPL | Lipoprotein lipase |
| MACE | Major Adverse Cardiovascular Events |
| MI | Myocardial infarction |
| MTP | Microsomal triglyceride transfer protein |
| NICE | National Institute for Health and Care Excellence |
| NPC1L1 | Niemann-Pick C1-like 1 |
| OATP | Organic anion-transporting polypeptide |
| oxLDL | Oxidized low-density lipoprotein |
| PAD | Peripheral arterial disease |
| PCE | Pooled Cohort Equations |
| PCOS | Polycystic ovary syndrome |
| PRE-CISE-IVUS | Plaque Regression with Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by Intravascular Ultrasound |
| PUFAs | Polyunsaturated fats |
| SAMS | Statin-associated musculoskeletal symptoms |
| SHARPP | Study of Heart and Renal Protection |
| SR-BI | Scavenger receptor class B type I |
| TG | Triglycerides |
| UGT | Uridine diphosphate glucuronosyltransferases |
| ULN | Upper Limit of Normal |
| VLDL | Very-low-density lipoprotein |